Process Development for a 1H-Indazole Synthesis Using an Intramolecular Ullmann-Type Reaction.

Area of Science:

• Organic Chemistry
• Pharmaceutical Synthesis
• Process Chemistry

Background:

• Established routes to fluorinated indazoles present safety and selectivity issues.
• A novel synthetic pathway is required for efficient pharmaceutical intermediate production.
• Fluorinated indazoles are critical building blocks in active pharmaceutical ingredient (API) synthesis.

Purpose of the Study:

• To develop a concise and improved synthetic route for a fluorinated indazole intermediate.
• To address safety and selectivity concerns associated with existing synthetic methods.
• To optimize reaction conditions for high yield and purity of the target indazole.

Main Methods:

• Electrophilic directed metalation and formylation sequence.
• Condensation with methyl hydrazine to form a hydrazone intermediate.
• Copper-catalyzed intramolecular Ullmann cyclization.
• High-throughput screening and statistical modeling for reaction optimization.
• Development of an unusual isolation method for fine chemicals.

Main Results:

• Successful synthesis of the desired fluorinated indazole intermediate.
• Overcame poor reactivity and thermal hazard concerns in the Ullmann cyclization.
• Identified safe and optimal reaction conditions through systematic screening and modeling.
• Achieved high-purity isolated material in excellent yields at laboratory scale.

Conclusions:

• The developed route offers a concise, safe, and efficient alternative for fluorinated indazole synthesis.
• Optimization strategies, including high-throughput screening, successfully addressed challenges in Ullmann cyclization.
• The new method provides a scalable and reliable process for producing high-quality pharmaceutical intermediates.